"Neoplasm Grading" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.
Descriptor ID |
D060787
|
MeSH Number(s) |
E01.789.612
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Grading".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Grading".
This graph shows the total number of publications written about "Neoplasm Grading" by people in this website by year, and whether "Neoplasm Grading" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2012 | 0 | 6 | 6 |
2013 | 0 | 15 | 15 |
2014 | 0 | 5 | 5 |
2015 | 0 | 11 | 11 |
2016 | 0 | 9 | 9 |
2017 | 0 | 9 | 9 |
2018 | 0 | 10 | 10 |
2019 | 0 | 5 | 5 |
2020 | 0 | 7 | 7 |
2021 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Grading" by people in Profiles.
-
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. Nat Commun. 2021 12 21; 12(1):7349.
-
The Substantial Omission of Indicated Postoperative Radiotherapy in Patients With Advanced-Stage Oral Cancer in the US-A Call to Action. JAMA Otolaryngol Head Neck Surg. 2021 10 01; 147(10):907-909.
-
Trend Analysis of Cutaneous Squamous Cell Carcinoma of the External Lip From 1975 to 2016. JAMA Otolaryngol Head Neck Surg. 2021 07 01; 147(7):624-631.
-
Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas. PLoS One. 2020; 15(12):e0244383.
-
PReferentially expressed antigen in MElanoma (PRAME) expression in BRCA1-associated protein (BAP1)-inactivated melanocytic tumors and deep penetrating nevi: A pilot study. J Cutan Pathol. 2021 Apr; 48(4):597-600.
-
Single-cell analysis of copy-number alterations in serous ovarian cancer reveals substantial heterogeneity in both low- and high-grade tumors. Cell Cycle. 2020 11; 19(22):3154-3166.
-
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma. J Clin Oncol. 2020 10 10; 38(29):3407-3417.
-
Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer. Cancer Treat Res Commun. 2020; 24:100193.
-
Machine learning assisted DSC-MRI radiomics as a tool for glioma classification by grade and mutation status. BMC Med Inform Decis Mak. 2020 07 06; 20(1):149.
-
Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer. Clin Cancer Res. 2020 07 01; 26(13):3117-3125.